Stock Analysis on Net
Stock Analysis on Net

Edwards Lifesciences Corp. (NYSE:EW)

Common-Size Balance Sheet: Assets
Quarterly Data

Beginner level

Edwards Lifesciences Corp., common-size consolidated balance sheet: assets (quarterly data)

Microsoft Excel LibreOffice Calc
Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Cash and cash equivalents 15.06 14.06 10.91 18.17 19.89 13.04 12.97 13.41 21.17 21.57 21.06 14.37 11.48 9.89 17.14 20.62 14.87 9.13 13.01 17.70 16.67 16.56 13.10
Short-term investments 3.99 4.05 6.06 5.21 2.85 3.72 4.64 4.55 5.61 3.07 4.67 9.12 14.08 12.14 2.07 7.56 12.80 17.04 11.69 12.47 15.59 22.49 26.20
Accounts receivable, net of allowances 8.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other receivables 1.79 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts and other receivables, net of allowances (legacy) 0.00 8.84 9.63 9.23 9.55 10.94 10.57 10.09 8.90 9.15 7.67 8.11 8.65 9.94 10.67 9.19 10.47 10.51 10.08 8.48 8.73 9.73 9.90
Inventories 11.37 11.44 10.90 9.88 10.24 11.21 11.54 11.40 9.80 9.99 9.85 9.74 9.81 9.57 9.02 8.79 9.24 9.07 9.25 8.37 8.60 8.68 8.56
Deferred income taxes 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.04 1.81 1.63
Prepaid expenses 1.01 0.89 1.08 0.91 0.96 1.00 1.01 1.02 0.88 1.23 1.34 1.06 0.96 1.05 1.11 1.02 1.15 1.23 1.27 1.11 1.23 1.28 1.28
Other current assets 2.52 2.59 2.69 2.59 2.42 2.34 2.59 2.48 2.52 2.41 2.04 2.05 1.77 1.85 2.21 2.48 1.52 2.01 1.91 2.32 2.49 3.12 3.97
Current assets 43.82% 41.88% 41.27% 45.99% 45.92% 42.25% 43.31% 42.96% 48.88% 47.41% 46.64% 44.46% 46.76% 44.44% 42.22% 49.67% 50.04% 49.00% 47.21% 50.45% 55.34% 63.66% 64.64%
Long-term accounts receivable, net of allowances 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.12 0.13 0.15 0.09 0.14 0.18 0.16
Long-term investments 8.81 9.25 9.67 9.02 6.47 7.41 8.30 9.51 8.04 8.27 9.13 9.95 10.34 10.73 10.86 11.80 10.77 9.67 9.58 9.36 9.44 9.00 7.33
Property, plant, and equipment, net 18.77 18.61 18.11 16.34 16.32 16.71 16.31 16.30 13.86 13.55 12.22 11.93 11.84 12.22 12.32 12.86 12.53 12.74 12.90 11.89 11.73 12.49 12.76
Operating lease right-of-use assets 1.32 1.32 1.24 1.23 1.23 1.28 1.28 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Goodwill 17.20 18.18 19.19 18.00 19.39 21.06 20.17 20.89 18.84 19.67 19.65 19.78 17.86 18.78 19.77 13.88 14.52 15.54 16.37 15.48 16.02 10.28 10.56
Other intangible assets, net 4.89 5.19 5.51 5.19 6.39 6.92 6.24 6.45 7.85 8.20 8.25 8.22 7.56 7.95 8.41 4.54 4.77 5.15 5.29 5.06 5.35 0.52 0.59
Deferred income taxes 3.16 3.18 2.60 2.65 2.61 2.94 3.01 3.27 1.93 2.29 3.11 3.75 3.59 3.60 3.75 4.52 4.36 4.66 5.10 4.45 0.55 2.27 2.43
Other assets 2.03 2.39 2.39 1.57 1.68 1.44 1.38 0.63 0.59 0.61 0.99 1.91 2.05 2.27 2.67 2.73 2.88 3.12 3.40 3.23 1.42 1.60 1.53
Long-term assets 56.18% 58.12% 58.73% 54.01% 54.08% 57.75% 56.69% 57.04% 51.12% 52.59% 53.36% 55.54% 53.24% 55.56% 57.78% 50.33% 49.96% 51.00% 52.79% 49.55% 44.66% 36.34% 35.36%
Total assets 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (filing date: 2020-10-26), 10-Q (filing date: 2020-07-27), 10-Q (filing date: 2020-04-28), 10-K (filing date: 2020-02-14), 10-Q (filing date: 2019-10-25), 10-Q (filing date: 2019-07-26), 10-Q (filing date: 2019-04-26), 10-K (filing date: 2019-02-15), 10-Q (filing date: 2018-10-26), 10-Q (filing date: 2018-07-27), 10-Q (filing date: 2018-04-27), 10-K (filing date: 2018-02-16), 10-Q (filing date: 2017-10-27), 10-Q (filing date: 2017-07-28), 10-Q (filing date: 2017-04-28), 10-K (filing date: 2017-02-17), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-29), 10-Q (filing date: 2016-04-29), 10-K (filing date: 2016-02-19), 10-Q (filing date: 2015-10-29), 10-Q (filing date: 2015-07-29), 10-Q (filing date: 2015-04-29).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Edwards Lifesciences Corp.’s current assets as a percentage of total assets increased from Q1 2020 to Q2 2020 and from Q2 2020 to Q3 2020.
Property, plant, and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Edwards Lifesciences Corp.’s property, plant, and equipment, net as a percentage of total assets increased from Q1 2020 to Q2 2020 and from Q2 2020 to Q3 2020.
Long-term assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Edwards Lifesciences Corp.’s long-term assets as a percentage of total assets decreased from Q1 2020 to Q2 2020 and from Q2 2020 to Q3 2020.